The total gastroparesis prevalent population in the 7MM was 34,057,658 in 2019. Among the major types of Gastroparesis, i.e., idiopathic, diabetic, and post surgical Gastroparesis, Idiopathic Gastroparesis accounted for a higher number of gastroparesis cases.
In 2019, there were approximately 14,665,140 cases of idiopathic Gastroparesis, and 8,621,552 cases for diabetic Gastroparesis in the 7MM.
The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019, as per Delveinsight analysis, the market size of Gastroparesis is expected to change during the forecast period.
Some of the key Pharmaceutical companies in the Gastroparesis market include Allergan, Evoke Pharma, Vanda Pharmaceuticals, Takeda, CinRx Pharma, and many others.
For more details visit:
https://www.delveinsight.com/blog/gastroparesis-market-landscape/